Bad news for Biogen: The FDA has not approved the drug...

Bad news for Biogen: The FDA has not approved the drug...
Bad news for Biogen: The FDA has not approved the drug...

If you want to specialize in the capital market and have a big head and motivation, you can suit us.

The job can be part-time; Flexibility in working hours; Work from home too

Priority (optional) for writing experience and basic knowledge of the capital market.

Leave details and we will get back to you

Thank you for leaving details, we will try to get back to you soon

According to the release, the FDA claimed that Biogen’s drug had failed to show effectiveness in treatment. This contradicts a report submitted to the FDA earlier this week by the advisory committee. Recall that the company’s share jumped more than 40% last Wednesday against the background of the report.

These were the details of the news Bad news for Biogen: The FDA has not approved the drug... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Future global challenges requires human capital building, says expert panel
NEXT US Fed holds key rate steady for fourth straight meeting